It was generally better tolerated and had fewer side effects as compared with the average adult population. A total of 175 children 5 to 18 years old were enrolled and divided in two groups: 102 were ...

Latanoprost is a generic prescription medication. The Food and Drug Administration (FDA) has approved it to treat increased pressure in the eyes. The drug is for use in adults who have either ...

We write in response to Mr Dubois and Ms Titcomb regarding the controversy over the switch from Xalatan to generic latanoprost. 1, 2 We prospectively studied our patients’ experience and the impact of ...

Jan. 2, 2003 -- The U.S. Food and Drug Administration (FDA) has approved the once-daily prescription eye drop latanoprost (Xalatan) as an initial treatment for elevated intraocular pressure (IOP) ...

Peapack, New Jersey (May 2, 2002) - Data presented for the first time at the XXIXth International Congress of Ophthalmology in Sydney, Australia, show that long-term (5-year) adjunctive treatment with ...

PRAGUE, Czech Republic — Latanoprost demonstrated better intraocular pressure (IOP) reduction than brimonidine in a recently concluded European drug study. In addition, latanoprost was better ...

Clermont Pharmaceuticals announced positive results from its Phase 3 study of non-preserved latanoprost for the treatment of glaucoma. In the study, non-preserved latanoprost was compared to Xalatan ...

(RTTNews) - Glenmark Pharmaceuticals Ltd. (GLENMARK.NS), Friday announced that it has introduced Latanoprost Ophthalmic Solution, 0.005 percent, a bioequivalent and therapeutically equivalent ...

This article is part of MPR’s coverage of the American Academy of Ophthalmology 2019 Meeting, taking place in San Francisco, CA. Our staff will report on medical research related to eye disorders, ...

I congratulate the authors of this study. 1 It is, to my knowledge, the first published study on the real world experience of patients receiving generic versions of latanoprost available in the UK.